Overexpression of MLH-1 and psoriasin genes in cutaneous angiofibromas from tuberous sclerosis complex patients

Journal of Cutaneous Pathology

Volumn 33, Issue 9, 2006, Pages 608-613

  La Placa, Michelangelo ^a   Gibellini, Davide ^a   Bianchi, Tommaso ^a   Patrizi, Annalisa ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN MLH1; PSORIASIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; HEMANGIOFIBROMA; HUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUBEROUS SCLEROSIS;

ANGIOFIBROMA; CALCIUM-BINDING PROTEINS; CARRIER PROTEINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; TUBEROUS SCLEROSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33748543229     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2006.00483.x     Document Type: Article

References (25)

1. Gomez MR, Sampson JR, Holets-Whittemore V. Tuberous sclerosis complex, 3rd edn. New York, NY: Oxford University Press, 1999.
2. Arbiser JL, Brat D, Hunter S, et al. Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. J Am Acad Dermatol 2002; 46: 376.
3. Sampson JR, Harris PC. The molecular genetics of tuberous sclerosis. Hum Mol Genet 1994; 3: 1477.
4. Yamamoto T, Pipo JR, Feng J-H, et al. Novel TSC1 and TSC2 mutations in Japanese patients with tuberous sclerosis complex. Brain Dev 2002; 24: 227.
5. Sancak O, Nellist M, Goedbloed M, et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur J Hum Genet 2005; 13: 576.
6. Narayanan V. Tuberous sclerosis complex: genetics to pathogenesis. Pediatr Neurol 2003; 29: 404.
7. Ali M, Girimaji SC, Markandaya M, et al. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex. Acta Neurol Scand 2005; 111: 54.
8. Al-Haddad S, Zhang Z, Leygue E, et al. Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol 1999; 155: 2057.
9. Baranovskaya S, Soto JS, Perucho M, Malkhosyan SR. Functional significance of concomitant inactivation of hMLH-1 and hMSH-6 in tumor cells of the microsatellite mutator phenotype. Proc Natl Acad Sci USA 2001; 98: 15107.
10. Jouvin-Marche E, Vigan I, Leroy V, Marche PN. Rapid cycle real time PCR, methods and applications. Berlin: Springer-Verlag, 2001.
11. Nystrom-Lahti M, Perrera C, Raschle M, et al. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer 2002; 33: 160.
12. Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997; 113: 1146.
13. Tanko Q, Franklin B, Lynch H, Knezetic J. A hMLH1 genomic mutation and associated novel mRNA defects in a hereditary non-polyposis colorectal cancer family. Mutat Res 2002; 503: 37.
14. Entius MM, Keller JJ, Drillenburg P, Kuypers KC, Giardello FM, Offerhaus GJ. Microsatellite instability and expression of hMLH-1 and MLH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res 2000; 6: 174.
15. Mathiak M, Rutten A, Mangold E, et al. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol 2002; 26: 338.
16. Alvino E, Marra G, Pagani E, et al. High-frequency microsatellite instability is associated with defective DNA mismatch repair in human melanoma. J Invest Dermatol 2002; 118: 79.
17. Hussein MR, Roggero E, Sudilovsky EC, Tuthill RJ, Woods GS, Sudilovsky O. Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi and cutaneous malignant melanomas. Am J Dermatopathol 2001; 23: 308.
18. Matias-Guiu X, Catasus L, Bussaglia E, et al. Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 2001; 32: 569.
19. Shcherbakova PV, Kunkel TA. Mutator phenotypes conferred by MLH-1 overexpression and by heterozygosity for mlh1 mutations. Mol Cell Biol 1999; 19: 3177.
20. Shcherbakova PV, Hall MC, Lewis MS, et al. Inactivation of DNA mismatch repair by increased expression of yeast MLH1. Mol Cell Biol 2001; 21: 940.
21. Zhang H, Richards B, Wilson T, et al. Apoptosis induced by overexpression of hMSH2 or hMLH1. Cancer Res 1999; 59: 3021.
22. Watson PH, Leygue ER, Murphy LC. Psoriasin (S100A7). Int J Biochem Cell Biol 1998; 30: 567.
23. Enerbach C, Porter DA, Seth P, et al. Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res 2002; 62: 43.
24. Ostergaard M, Wolf H, Orntoft TF, Celis JE. Psoriasin: a putative urinary marker for the follow-up of patients with bladder squamous cell carcinoma. Electrophoresis 1999; 20: 349.
25. Di Nuzzo S, Sylva-Steenland BM, Koomen CW, et al. Exposure to UVB induces accumulation of LFA-1+ T cells and enhanced expression of the chemokine psoriasin in normal human skin. Photochem Photobiol 2000; 72: 374.